Average Insider

Where insiders trade, we follow

Insider Buy/Sell Ratio for March 2026

Extreme outlier transactions (>3ฯƒ) are excluded.Show All Data
Ratio0.2:1
Daily Buy & Sell Volume

By Sector

By Industry

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
90
Price
$324.65
Total Value
$29.22K
Shares Held After
24,973
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Fitzgerald Kevin Joseph โ€” CSO & EVP, Head of Research
Mar 2, 2026
Sale
Shares
47
Price
$323.62
Total Value
$15.21K
Shares Held After
25,063
% of Holdings
0.2%

ALKAMI TECHNOLOGY, INC. (ALKT)

Linebarger Douglas A. โ€” Chief Legal Officer
Mar 2, 2026
Sale
Shares
5,518
Price
$16.90
Total Value
$93.25K
Shares Held After
216,233
% of Holdings
2.5%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
4,198
Price
$1.43
Total Value
$6.00K
Shares Held After
170,736
% of Holdings
2.4%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
2,461
Price
$1.43
Total Value
$3.52K
Shares Held After
174,934
% of Holdings
1.4%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
3,068
Price
$1.43
Total Value
$4.39K
Shares Held After
177,395
% of Holdings
1.7%

Pulmonx Corp (LUNG)

Radhakrishnan Srikanth โ€” Chief Science &Techn. Officer
Mar 2, 2026
Sale
Shares
756
Price
$1.43
Total Value
$1.08K
Shares Held After
180,463
% of Holdings
0.4%

Penumbra Inc (PEN)

Yuen Maggie โ€” Chief Financial Officer
Mar 2, 2026
Sale
Shares
2,432
Price
$342.30
Total Value
$832.47K
Shares Held After
18,353
% of Holdings
11.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
53
Price
$332.64
Total Value
$17.63K
Shares Held After
64,273
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
129
Price
$331.93
Total Value
$42.82K
Shares Held After
64,326
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
112
Price
$330.85
Total Value
$37.06K
Shares Held After
64,455
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
234
Price
$329.71
Total Value
$77.15K
Shares Held After
64,567
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
138
Price
$328.71
Total Value
$45.36K
Shares Held After
64,801
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
454
Price
$327.67
Total Value
$148.76K
Shares Held After
64,939
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
541
Price
$326.81
Total Value
$176.80K
Shares Held After
65,393
% of Holdings
0.8%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
356
Price
$325.63
Total Value
$115.92K
Shares Held After
65,934
% of Holdings
0.5%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
124
Price
$324.65
Total Value
$40.26K
Shares Held After
66,290
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Poulton Jeffrey V. โ€” EVP, Chief Financial Officer
Mar 2, 2026
Sale
Shares
65
Price
$323.62
Total Value
$21.04K
Shares Held After
66,414
% of Holdings
0.1%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
42
Price
$332.64
Total Value
$13.97K
Shares Held After
25,181
% of Holdings
0.2%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
101
Price
$331.93
Total Value
$33.52K
Shares Held After
25,223
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
87
Price
$330.85
Total Value
$28.78K
Shares Held After
25,324
% of Holdings
0.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
182
Price
$329.71
Total Value
$60.01K
Shares Held After
25,411
% of Holdings
0.7%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
107
Price
$328.71
Total Value
$35.17K
Shares Held After
25,593
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
353
Price
$327.67
Total Value
$115.67K
Shares Held After
25,700
% of Holdings
1.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
421
Price
$326.81
Total Value
$137.59K
Shares Held After
26,053
% of Holdings
1.6%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
277
Price
$325.63
Total Value
$90.20K
Shares Held After
26,474
% of Holdings
1.0%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
97
Price
$324.65
Total Value
$31.49K
Shares Held After
26,751
% of Holdings
0.4%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Garg Pushkal โ€” EVP Chief R&D
Mar 2, 2026
Sale
Shares
50
Price
$323.62
Total Value
$16.18K
Shares Held After
26,848
% of Holdings
0.2%
Mar 2, 2026
Sale
Shares
1,300
Price
$129.95
Total Value
$168.93K
Shares Held After
1,784
% of Holdings
42.2%
Mar 2, 2026
Sale
Shares
3,600
Price
$128.87
Total Value
$463.94K
Shares Held After
3,084
% of Holdings
53.9%
Mar 2, 2026
Sale
Shares
3,100
Price
$127.90
Total Value
$396.49K
Shares Held After
6,684
% of Holdings
31.7%
Mar 2, 2026
Sale
Shares
578
Price
$70.46
Total Value
$40.73K
Shares Held After
767,780
% of Holdings
0.1%
Mar 2, 2026
Sale
Shares
15,322
Price
$69.80
Total Value
$1.07M
Shares Held After
768,358
% of Holdings
2.0%

Pulmonx Corp (LUNG)

Lehman David Aaron โ€” GENERAL COUNSEL
Mar 2, 2026
Sale
Shares
4,051
Price
$1.43
Total Value
$5.79K
Shares Held After
240,755
% of Holdings
1.7%
Mar 2, 2026
Sale
Shares
4,100
Price
$69.20
Total Value
$283.71K
Shares Held After
783,680
% of Holdings
0.5%

Pulmonx Corp (LUNG)

Lehman David Aaron โ€” GENERAL COUNSEL
Mar 2, 2026
Sale
Shares
2,590
Price
$1.43
Total Value
$3.70K
Shares Held After
244,806
% of Holdings
1.0%

Pulmonx Corp (LUNG)

Lehman David Aaron โ€” GENERAL COUNSEL
Mar 2, 2026
Sale
Shares
4,433
Price
$1.43
Total Value
$6.34K
Shares Held After
247,396
% of Holdings
1.8%

Pulmonx Corp (LUNG)

Lehman David Aaron โ€” GENERAL COUNSEL
Mar 2, 2026
Sale
Shares
1,163
Price
$1.43
Total Value
$1.66K
Shares Held After
251,829
% of Holdings
0.5%

Vanda Pharmaceuticals Inc. (VNDA)

Moran Kevin Patrick โ€” SVP, CFO & Treasurer
Mar 2, 2026
Sale
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%

Vanda Pharmaceuticals Inc. (VNDA)

Williams Timothy โ€” SVP & General Counsel
Mar 2, 2026
Sale
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%

ORMAT TECHNOLOGIES, INC. (ORA)

Woelfel Jessica โ€” GC, CCO, and CS
Mar 2, 2026
Sale
Shares
869
Price
$104.59
Total Value
$90.89K
Shares Held After
5,792
% of Holdings
13.0%

Septerna, Inc. (SEPN)

Shaikhly Samira โ€” Chief People Officer
Mar 2, 2026
Sale
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%

Septerna, Inc. (SEPN)

Shaikhly Samira โ€” Chief People Officer
Mar 2, 2026
Sale
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%

Vanda Pharmaceuticals Inc. (VNDA)

Wijkstrom Joakim โ€” SVP, Chief Marketing Officer
Mar 2, 2026
Sale
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%

ENERGY FUELS INC (UUUU)

Moore Curtis โ€” Senior VP, Marketing &
Mar 2, 2026
Sale
Shares
10,000
Price
$23.12
Total Value
$231.18K
Shares Held After
112,415
% of Holdings
8.2%

MediaAlpha, Inc. (MAX)

Yi Steven โ€” Director
Mar 2, 2026
Sale
Shares
39,252
Price
$9.99
Total Value
$392.00K
Shares Held After
2,649,624
% of Holdings
1.5%

Montrose Environmental Group, Inc. (MEG)

Afsari Nasym โ€” General Counsel and Secretary
Mar 2, 2026
Sale
Shares
200
Price
$30.00
Total Value
$6.00K
Shares Held After
204,878
% of Holdings
0.1%

JFrog Ltd (FROG)

Notman Tali โ€” CHIEF REVENUE OFFICER
Mar 2, 2026
Sale
Shares
35,856
Price
$4,015.00
Total Value
$143.96M
Shares Held After
773,695
% of Holdings
4.4%
Mar 2, 2026
Sale
Shares
459
Price
$29.89
Total Value
$13.72K
Shares Held After
62,614
% of Holdings
0.7%
Mar 2, 2026
Sale
Shares
9,541
Price
$28.82
Total Value
$274.97K
Shares Held After
63,073
% of Holdings
13.1%
Version: v26.3.33